True Mark Investments, LLC Relay Therapeutics, Inc. Transaction History
True Mark Investments, LLC
- $382 Billion
- Q1 2025
A detailed history of True Mark Investments, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, True Mark Investments, LLC holds 51,536 shares of RLAY stock, worth $159,761. This represents 0.04% of its overall portfolio holdings.
Number of Shares
51,536
Previous 55,400
6.97%
Holding current value
$159,761
Previous $228 Million
40.84%
% of portfolio
0.04%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding RLAY
# of Institutions
212Shares Held
159MCall Options Held
100KPut Options Held
26.8K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$86.5 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$46.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$32.7 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.95MShares$27.7 Million3.17% of portfolio
-
Tang Capital Management LLC San Diego, CA8.07MShares$25 Million2.5% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $373M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...